Mechanistically, NFκB inhibited the transcriptional activity of PXR (e.g., on hepatic cytochrome P450 genes involved in xenobiotic detoxification) and, in turn, suggested a druggable PXR-NFκB axis to prevent infection and xenobiotic-induced inflammation, tissue damage, and immune cell dysfunction. The gene discussed is NR1I2; the disease is infection.